US Bancorp’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
30,729
+5,317
+21% +$214K ﹤0.01% 1105
2026
Q1
$1.13M Buy
25,412
+3,000
+13% +$132K ﹤0.01% 1090
2025
Q4
$941K Buy
+22,412
New +$946K ﹤0.01% 1172

Other funds holding MDLN

US Bancorp's MDLN Position: Q2 2026 in Review

US Bancorp increased its Medline Inc (MDLN) stake by 21% in Q2 2026, buying an estimated $214K and bringing the position to 30,729 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1105.

US Bancorp first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • US Bancorp held 30,729 shares of Medline Inc worth $1.21M as of Q2 2026.
  • US Bancorp bought 5,317 Medline Inc shares in Q2 2026, an estimated $214K.
  • Medline Inc made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1105 holding.
  • US Bancorp first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.